The delisting risk has been deferred, which should provide short-term relief to the stock price given the company's tiny $5M market cap. Monitor the next quarterly report (10-Q) closely for the stockholders' equity line — any drop toward the $2.5M threshold would be a critical red flag under the no-cure monitoring regime. Watch for any financing or capital raise that could shore up equity but dilute existing holders.
Price Chart
Executive Summary
DNA X (SONM) received a Nasdaq Hearings Panel letter confirming it has regained compliance with the minimum $2.5M stockholders' equity requirement (Listing Rule 5550(b)(1)), removing the immediate delisting threat. However, the company remains under a mandatory panel monitor through August 28, 2027, and faces stringent limitations if it falls out of compliance again — no plan-of-compliance cure, no extension, and direct referral to delisting proceedings. This is a positive procedural step that buys time, but the ongoing monitoring period and harsh consequences for any re-violation keep the situation fragile.
Key Facts
- On August 28, 2026, Nasdaq Hearings Panel notified DNA X that it has regained compliance with Listing Rule 5550(b)(1) requiring minimum $2.5M stockholders' equity.
- The panel decision from July 24, 2026, continues in effect; securities remain subject to delisting if the company fails to maintain compliance with all Nasdaq listing rules through November 18, 2026.
- Company is subject to a mandatory panel monitor until August 28, 2027.
- If Staff finds the company again out of compliance with the stockholders' equity requirement during the one-year monitoring period, no compliance-plan cure period will be permitted, no additional time granted, and Staff will issue a delisting determination letter — with an opportunity to request a new hearing before the Panel.
Financial Impact
No dollar amounts provided in the filing; the key financial threshold is the $2.5M minimum stockholders' equity requirement.
Risk Factors
- Any future violation of the $2.5M stockholders' equity requirement during the monitoring period triggers immediate delisting proceedings with no cure period, no extension, and no compliance-plan alternative — high-stakes outcome for a $5M market-cap company.
- Maintaining compliance through November 18, 2026, and then through the one-year monitor to August 28, 2027, is not guaranteed — a negative earnings surprise or asset write-down could push equity below threshold.
- The company's small market cap ($5M) and historically volatile stock price amplify downside if any compliance setback occurs.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-040845 |
| Document: 0001493152-26-040845-index-headers.html | 0001493152-26-040845 |
| Document: 0001493152-26-040845-index.html | 0001493152-26-040845 |
| Document: 0001493152-26-040845.txt | 0001493152-26-040845 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 31, 2026 8w ago | 8-K | $3.53 $4.57 | ▲ +29.50% | ▲ +29.19% | $2.96 (−16.03%) |
Aug 27, 2026 8w ago | 8-K | $3.27 $4.06 | ▲ +24.16% | ▲ +24.26% | $2.96 (−9.48%) |
Aug 19, 2026 9w ago | Press Release | $3.44 $2.96 | ▲ +13.95% | ▲ +13.95% | $2.96 (+13.95%) |
Jul 2, 2026 16w ago | 8-K | $3.75 $3.25 | ▲ +13.33% | ▲ +12.92% | $2.96 (+21.07%) |
Jun 12, 2026 19w ago | EFFECT | $4.74 $4.05 | ▲ +14.56% | ▲ +16.34% | $2.96 (+37.55%) |
Jun 4, 2026 20w ago | 8-K | $4.75 $4.21 | ▼ −11.37% | ▼ −13.23% | $2.96 (−37.68%) |
May 27, 2026 21w ago | 8-K | $4.24 $5.70 | ▼ −34.43% | ▼ −37.58% | $2.96 (+30.19%) |
Apr 30, 2026 25w ago | 8-K / 10-K/A | $4.89 $4.73 | ▲ +3.27% | ▲ +8.56% | $2.96 (+39.47%) |
Apr 14, 2026 27w ago | 8-K | $3.15 $5.10 | ▲ +61.90% | ▲ +55.86% | $2.96 (−6.03%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers